GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paramount Bed Holdings Co Ltd (TSE:7817) » Definitions » Research & Development

Paramount Bed Holdings Co (TSE:7817) Research & Development : 円0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Paramount Bed Holdings Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Paramount Bed Holdings Co's Research & Development for the three months ended in Dec. 2023 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was 円0 Mil.


Paramount Bed Holdings Co Research & Development Historical Data

The historical data trend for Paramount Bed Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paramount Bed Holdings Co Research & Development Chart

Paramount Bed Holdings Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Paramount Bed Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Paramount Bed Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paramount Bed Holdings Co  (TSE:7817) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Paramount Bed Holdings Co Research & Development Related Terms

Thank you for viewing the detailed overview of Paramount Bed Holdings Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Paramount Bed Holdings Co (TSE:7817) Business Description

Traded in Other Exchanges
N/A
Address
14-5, Higashisuna, 2-chome, Koto-ku, Tokyo, JPN, 136-8671
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.

Paramount Bed Holdings Co (TSE:7817) Headlines

No Headlines